MD679G2 - Комплех включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, их получение и содержащие их фармацевтические композиции, способ их получения и способ лечения - Google Patents

Комплех включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, их получение и содержащие их фармацевтические композиции, способ их получения и способ лечения

Info

Publication number
MD679G2
MD679G2 MD94-0333A MD940333A MD679G2 MD 679 G2 MD679 G2 MD 679G2 MD 940333 A MD940333 A MD 940333A MD 679 G2 MD679 G2 MD 679G2
Authority
MD
Moldova
Prior art keywords
preparation
morpholinsydnonimine
ethoxycarbonyl
salts
cyclodextrin
Prior art date
Application number
MD94-0333A
Other languages
English (en)
Romanian (ro)
Other versions
MD679F1 (en
Inventor
Andrasne Vikmon
Jozsef Szejtli
Jozsef Gaal
Istvan Hermecz
Agnes Horvath
Katalin Marmarosi
Gabor Horvath
Iren Munkacsi
Original Assignee
Chinoin Gyogyszer -Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer -Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer -Es Vegyeszeti Termekek Gyara Rt.
Publication of MD679F1 publication Critical patent/MD679F1/xx
Publication of MD679G2 publication Critical patent/MD679G2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к комплексу включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, к способу их получения и к содержащим их фармацевтическим композициям.Комплекс включения N- этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными получают путем:а) взаимодействия N- этоксикарбонил-3-морфолино-сиднонимина или его солей с производным циклодекстрина в среде растворителя и выделения комплекса из раствора путем дегидратации, или проводят:б) очень энергичное размалывание N- этоксикарбонил-3-морфолино-сиднонимина или его солей с производным циклодекстрина.
MD94-0333A 1990-03-28 1994-08-25 Комплех включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, их получение и содержащие их фармацевтические композиции, способ их получения и способ лечения MD679G2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU901868A HU210921B (en) 1990-03-28 1990-03-28 Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
PCT/HU1991/000012 WO1991014680A1 (en) 1990-03-28 1991-03-28 Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
MD679F1 MD679F1 (en) 1997-02-28
MD679G2 true MD679G2 (ru) 1997-11-30

Family

ID=10956592

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0333A MD679G2 (ru) 1990-03-28 1994-08-25 Комплех включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, их получение и содержащие их фармацевтические композиции, способ их получения и способ лечения

Country Status (34)

Country Link
US (1) US5403840A (ru)
EP (1) EP0477315B1 (ru)
JP (1) JP2582497B2 (ru)
KR (1) KR950004705B1 (ru)
CN (1) CN1051080C (ru)
AT (1) ATE138656T1 (ru)
AU (1) AU638824B2 (ru)
BG (1) BG61689B1 (ru)
BR (1) BR9105136A (ru)
CA (1) CA2054188C (ru)
CZ (1) CZ287353B6 (ru)
DE (1) DE69119853T2 (ru)
DK (1) DK0477315T3 (ru)
ES (1) ES2090320T3 (ru)
FI (1) FI102460B1 (ru)
GE (1) GEP19991832B (ru)
GR (1) GR3020684T3 (ru)
HR (1) HRP920561B1 (ru)
HU (1) HU210921B (ru)
IL (1) IL97714A (ru)
LT (1) LT3394B (ru)
LV (1) LV10245B (ru)
MC (1) MC2185A1 (ru)
MD (1) MD679G2 (ru)
NO (1) NO179611C (ru)
OA (1) OA10029A (ru)
PL (1) PL165868B1 (ru)
RO (1) RO109649B1 (ru)
RU (1) RU2111216C1 (ru)
SI (1) SI9110908A (ru)
SK (1) SK279891B6 (ru)
TJ (1) TJ231R3 (ru)
UA (1) UA27226C2 (ru)
WO (1) WO1991014680A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3119C2 (ru) * 2000-02-24 2007-04-30 Therabel Pharmaceuticals Limited Медикаментозная форма для орального применения с пролонгированным высвобождением молсидомина

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
ITTO20120056A1 (it) * 2012-01-24 2013-07-25 Borla Ind Connettore per linee medicali di infusione, trasfusione e simili
ITTO20130433A1 (it) * 2013-05-29 2014-11-30 Borla Ind Connettore per linee medicali
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127468A2 (en) * 1983-05-26 1984-12-05 CASSELLA Aktiengesellschaft Percutaneous pharmaceutical preparations for external use
HUT52366A (en) * 1988-11-28 1990-07-28 Vectorpharma Int Process for producing pharmaceutical compositions with gradually soluble carrier

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
ES2037385T3 (es) * 1988-01-14 1993-06-16 Akzo N.V. Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
US5120732A (en) * 1988-06-14 1992-06-09 Cassella Aktiengesellschaft Substituted 3-aminosyndone imines, a process for their preparation and their use
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127468A2 (en) * 1983-05-26 1984-12-05 CASSELLA Aktiengesellschaft Percutaneous pharmaceutical preparations for external use
HUT52366A (en) * 1988-11-28 1990-07-28 Vectorpharma Int Process for producing pharmaceutical compositions with gradually soluble carrier

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3119C2 (ru) * 2000-02-24 2007-04-30 Therabel Pharmaceuticals Limited Медикаментозная форма для орального применения с пролонгированным высвобождением молсидомина

Also Published As

Publication number Publication date
HRP920561A2 (hr) 1994-04-30
LV10245A (lv) 1994-10-20
WO1991014680A1 (en) 1991-10-03
NO179611B (no) 1996-08-05
SK279891B6 (sk) 1999-05-07
NO914649D0 (no) 1991-11-27
LTIP386A (en) 1994-12-27
CN1051080C (zh) 2000-04-05
FI915569A0 (fi) 1991-11-26
HU901868D0 (en) 1990-08-28
SI9110908A (sl) 1998-06-30
HRP920561B1 (en) 1999-12-31
KR920701182A (ko) 1992-08-11
EP0477315A1 (en) 1992-04-01
CA2054188A1 (en) 1991-09-29
BR9105136A (pt) 1992-08-04
BG95531A (bg) 1993-12-24
NO914649L (no) 1991-11-27
ES2090320T3 (es) 1996-10-16
RO109649B1 (ro) 1995-04-28
OA10029A (en) 1996-10-14
CS85191A3 (en) 1991-11-12
ATE138656T1 (de) 1996-06-15
GR3020684T3 (en) 1996-10-31
JPH04506362A (ja) 1992-11-05
AU638824B2 (en) 1993-07-08
DE69119853D1 (de) 1996-07-04
MC2185A1 (fr) 1992-09-16
DE69119853T2 (de) 1996-10-10
US5403840A (en) 1995-04-04
RU2111216C1 (ru) 1998-05-20
PL165868B1 (pl) 1995-02-28
PL293022A1 (en) 1992-12-28
FI102460B (fi) 1998-12-15
NO179611C (no) 1996-11-13
IL97714A0 (en) 1992-06-21
LT3394B (en) 1995-09-25
CA2054188C (en) 1996-07-23
TJ231R3 (en) 1999-11-24
HUT58109A (en) 1992-01-28
LV10245B (en) 1995-08-20
DK0477315T3 (da) 1996-09-30
CZ287353B6 (cs) 2000-11-15
CN1056688A (zh) 1991-12-04
HU210921B (en) 1995-09-28
AU7574591A (en) 1991-10-21
BG61689B1 (bg) 1998-03-31
FI102460B1 (fi) 1998-12-15
UA27226C2 (uk) 2000-08-15
EP0477315B1 (en) 1996-05-29
IL97714A (en) 1995-03-30
MD679F1 (en) 1997-02-28
KR950004705B1 (ko) 1995-05-04
JP2582497B2 (ja) 1997-02-19
GEP19991832B (en) 1999-11-05

Similar Documents

Publication Publication Date Title
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
ES8403724A1 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
NO952151L (no) Injiserbare, taxanderivat-baserte preparater
DE2862384D1 (en) O-substituted (+)-cyanidan-3-ol derivatives, method for their preparation, as well as pharmaceutical compositions containing these compounds and their preparation
HUT49600A (en) Process for producing substituted flavonoid deriatives and salts, thereof, as well as pharmaceutical compositions comprising such compounds
PL231450A1 (en) Process for preparing novel derivatives of 3-phenoxy-1-alkylaminopropan-2-ol
IL50849A (en) 2-phenyl 6-carboxy(or tetrazol-5-yl)3,4-dihydro-quinazolin-4-one(thion)derivatives,process for their preparation and pharmaceutical compositions containing them
HUT50775A (en) Process for producing disubstituted pyridine derivatives and pharmaceutical compositions containing them as active components
MD679G2 (ru) Комплех включения N-этоксикарбонил-3-морфолино-сиднонимина или его солей с циклодекстрином или его производными, их получение и содержащие их фармацевтические композиции, способ их получения и способ лечения
DK0422497T3 (da) Inklusionskomplekser med Silybinin, deres fremstilling af farmaceutiske præparater, der indeholder dem
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
NL192387B (nl) Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.
MD776C2 (ru) Комплексы включения 3-морфолино-сиднонимина или его солей, или его таутомерного изомера с циклодекстрином или его производными, способ их получения, содержащие их фармацевтические композиции, способ их получения и лечения стенокардии или ишемической болезни
GB2006193A (en) Inclusion complexes of prostacyclin and its derivatives, their preparation and pharmaceutical compositions containing them
AU4347389A (en) Novel s-timolol derivative and process for its preparation
NL177209C (nl) Werkwijze voor het bereiden van reukstofpreparaten op basis van tricyclo(5.2.1.0Ÿ2Ÿ,Ÿ6Ÿ-)decyl-8-derivaten, alsmede werkwijze voor het bereiden van bij de bereiding van dergelijke reukstofpreparaten toe te passen tricyclo(5.2.1.0Ÿ2Ÿ,Ÿ6Ÿ-)decyl-8-derivaten.
ES8402819A1 (es) Procedimiento para la produccion de una 3,3-dialquil-o 3,3-dialquileno-indolina.
AU6554890A (en) (1r,2r)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides, process for their preparation and pharmaceutical compositions containing them
DE3461187D1 (en) N-cyclopropylmethyl-2-oxo-3-diparamethoxyphenyl-5,6-triazines, process for its preparation and their use as pharmaceutical preparations
IL49716A (en) 9a,11a,15-trihydroxy-16-thienyloxy(thienyloxy methyl)-tetranor prostadienoic acid derivatives,process for their preparation and pharmaceutical compositions containing them
ES8801291A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives

Legal Events

Date Code Title Description
PC3A Transfer or assignment (patent for invention)

Free format text: 19970812 TERABEL INDUSTRIES S.A., FR

IF99 Valid patent on 19990615

Free format text: EXPIRES: 20110328

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees